XORTX Therapeutics XRTX
NASDAQ XRTX
$1.79 +0.06 (+3.93%)
As of: Oct 2, 2026 · 10:52 AM EDT

XORTX Therapeutics (XRTX) Net Cash Flow (2022)

Updated

XORTX Therapeutics (XRTX) posted Net Cash Flow of -$1.64 million for the year ended Dec 31, 2025, compared with -$938,063 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Net Cash Flow (2022) Analysis & Trends

Since the year ended Dec 31, 2019, XORTX Therapeutics has reported Net Cash Flow for 7 years.

  • Annual Net Cash Flow has run from a low of -$6.99 million in the year ended Dec 31, 2023 to a high of $24.38 million in the year ended Dec 31, 2021 over five years.
  • Business Quant data shows XRTX's Net Cash Flow at -$938,063 in the year ended Dec 31, 2024, -$6.99 million in the year ended Dec 31, 2023, -$4.31 million in the year ended Dec 31, 2022 and $24.38 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 652.90 Mn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.40 Mn
Sep 30, 2022 -1.44 Mn
API Access

XORTX Therapeutics Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=XRTX&period=max&api_key=YOUR_API_KEY